Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interleukin-7 and interleukin-15 regulate the expression of thebcl-2 and c-myb genes in cutaneous T-cell lymphoma cells
Jian‐Zhong Qin, Chunlei Zhang, Jivko Kamarashev, et al.
Blood (2001) Vol. 98, Iss. 9, pp. 2778-2783
Closed Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Effector and memory T-cell differentiation: implications for vaccine development
Susan M. Kaech, E. John Wherry, Rafi Ahmed
Nature reviews. Immunology (2002) Vol. 2, Iss. 4, pp. 251-262
Open Access | Times Cited: 1784
IL-15/IL-15 receptor biology: A guided tour through an expanding universe
Vadim Budagian, Елена А. Буланова, Ralf Paus, et al.
Cytokine & Growth Factor Reviews (2006) Vol. 17, Iss. 4, pp. 259-280
Closed Access | Times Cited: 366
Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma
Anita G. Seto, Xuan Beatty, Joshua M. Lynch, et al.
British Journal of Haematology (2018) Vol. 183, Iss. 3, pp. 428-444
Open Access | Times Cited: 248
Molecular Pathways: Interleukin-15 Signaling in Health and in Cancer
Anjali Mishra, Laura A. Sullivan, Michael A. Caligiuri
Clinical Cancer Research (2014) Vol. 20, Iss. 8, pp. 2044-2050
Open Access | Times Cited: 197
TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL
Ilan R. Kirsch, Rei Watanabe, John T. O’Malley, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 308
Open Access | Times Cited: 197
Signaling mechanisms, interaction partners, and target genes of STAT6
Daniel Hebenstreit, Gerald Wirnsberger, Jutta Horejs‐Hoeck, et al.
Cytokine & Growth Factor Reviews (2006) Vol. 17, Iss. 3, pp. 173-188
Closed Access | Times Cited: 289
Down-regulating constitutive activation of the NF-κB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis
Aurore Sors, Francette Jean-Louis, C Pellet, et al.
Blood (2005) Vol. 107, Iss. 6, pp. 2354-2363
Open Access | Times Cited: 171
STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma
Katharina Kopp, Ulrik Ralfkiær, Lise Mette Rahbek Gjerdrum, et al.
Cell Cycle (2013) Vol. 12, Iss. 12, pp. 1939-1947
Open Access | Times Cited: 136
Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression
Elena Netchiporouk, Ivan V. Litvinov, Linda Moreau, et al.
Cell Cycle (2014) Vol. 13, Iss. 21, pp. 3331-3335
Open Access | Times Cited: 118
Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma
Anjali Mishra, Krista La Perle, Sonya Kwiatkowski, et al.
Cancer Discovery (2016) Vol. 6, Iss. 9, pp. 986-1005
Open Access | Times Cited: 87
Homeostatic control of lymphocyte survival: potential origins and implications
David R. Plas, Jeffrey C. Rathmell, Craig B. Thompson
Nature Immunology (2002) Vol. 3, Iss. 6, pp. 515-521
Closed Access | Times Cited: 159
Apoptotic detection methods — from morphology to gene
Yuki Otsuki, Zhuoyu Li, M Shibata
Progress in Histochemistry and Cytochemistry (2003) Vol. 38, Iss. 3, pp. 275-339
Open Access | Times Cited: 154
Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10.
Giorgio Stassi, Matilde Todaro, M Zerilli, et al.
PubMed (2003) Vol. 63, Iss. 20, pp. 6784-90
Closed Access | Times Cited: 145
T cell homeostasis in tolerance and immunity
Annette M. Marleau, Nora Sarvetnick
Journal of Leukocyte Biology (2005) Vol. 78, Iss. 3, pp. 575-584
Closed Access | Times Cited: 129
IL-15 enhances survival and function of HIV-specific CD8+ T cells
Yvonne M. Mueller, Paul Bojczuk, E. Scott Halstead, et al.
Blood (2003) Vol. 101, Iss. 3, pp. 1024-1029
Open Access | Times Cited: 129
STAT5 Is Critical To Maintain Effector CD8+ T Cell Responses
Pulak Tripathi, Sema Kurtuluş, Sara Wojciechowski, et al.
The Journal of Immunology (2010) Vol. 185, Iss. 4, pp. 2116-2124
Open Access | Times Cited: 118
Alternative Serotype Adenovirus Vaccine Vectors Elicit Memory T Cells with Enhanced Anamnestic Capacity Compared to Ad5 Vectors
Pablo Penaloza‐MacMaster, Nicholas M. Provine, Joshua Ra, et al.
Journal of Virology (2012) Vol. 87, Iss. 3, pp. 1373-1384
Open Access | Times Cited: 84
Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines
Ivan V. Litvinov, Brendan Cordeiro, Simon Fredholm, et al.
Cell Cycle (2014) Vol. 13, Iss. 18, pp. 2975-2982
Open Access | Times Cited: 70
Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
Kalyani Patil, Shilpa Kuttikrishnan, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 382-399
Open Access | Times Cited: 40
HDAC Inhibitors For The Treatment Of Cutaneous T-Cell Lymphomas
Sophia Rangwala, Chunlei Zhang, Madeleine Duvic
Future Medicinal Chemistry (2012) Vol. 4, Iss. 4, pp. 471-486
Closed Access | Times Cited: 65
Novel insights into the pathogenesis of T-cell lymphomas
John S. Van Arnam, Megan S. Lim, Kojo S.J. Elenitoba‐Johnson
Blood (2018) Vol. 131, Iss. 21, pp. 2320-2330
Open Access | Times Cited: 53
MiRNAs in primary cutaneous lymphomas
Xin Yu, Zheng Li, Jie Liu
Cell Proliferation (2015) Vol. 48, Iss. 3, pp. 271-277
Open Access | Times Cited: 51
STAT5 induces miR-21 expression in cutaneous T cell lymphoma
Lise M. Lindahl, Simon Fredholm, Claudine Joseph, et al.
Oncotarget (2016) Vol. 7, Iss. 29, pp. 45730-45744
Open Access | Times Cited: 49
Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients
Benoit M. Cyrenne, Julia M. Lewis, Jason Weed, et al.
Blood (2017) Vol. 130, Iss. 19, pp. 2073-2083
Open Access | Times Cited: 48
Romidepsin and Afatinib Abrogate Jak–Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma
Bobby B. Shih, Cindy Ma, José R. Cortés, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 7, pp. 1579-1589.e8
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top